T-B Coculture Assay

Overview

T-B coculture assays measure the functional capacity of T cell subsets to provide B cell help by co-incubating sorted T cells with autologous B cells and quantifying B cell differentiation outputs (plasmablast generation, antibody secretion, class switching). These assays can be combined with blocking antibodies to identify the cytokine mediators of T-B cooperation.

Key Points from Literature

  • Tph-driven memory B cell → plasmablast differentiation in dengue: Sorted CXCR5⁻PD-1⁺ (Tph) cells cocultured with autologous B cells drive memory B cell differentiation into plasmablasts. Naive B cells are poor responders to Tph-provided help — in contrast to the TLR7-driven EF pathway in SLE, where naive cells are the dominant ASC precursors (see Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue).

  • IL-21 blocking identifies dominant effector cytokine: Anti-IL-21 blocking antibody in the coculture system reduces plasmablast output by ~60%, establishing IL-21 as the primary but not exclusive mediator. The residual ~40% output likely reflects CD40L-mediated costimulation and/or other cytokines (see Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue).

  • Complements the Jenks2018 in vitro differentiation system: The Jenks2018 EF differentiation protocol (rNAV + TLR7 + IFN-γ + IL-21 → aNAV → DN2 → PB) uses purified cytokines without T cells. The Ansari2025 T-B coculture demonstrates that T cells (specifically Tph) can provide these signals physiologically, adding the T cell arm to the EF pathway model (see In Vitro B Cell Stimulation for the Jenks2018 approach).

  • ★ T cell coculture is the assay in which atypical B cells DO differentiate into plasma cells. Among the evidence the review assembles for ABCs being “transcriptionally and functionally primed for PC differentiation” is their increased propensity to differentiate into PCs in T cell coculture experiments (see Glaros2025 - Multilayered Identity of B Cell Memory, review, no original data, citing Wang 2018 Nat Commun — IL-21-driven expansion and PC differentiation of autoreactive CD11c^hi T-bet⁺ B cells in SLE; and Louis 2021 JCI Insight — T-bet⁺CD27⁺CD21⁻ B cells poised for PC differentiation in antibody-mediated kidney-transplant rejection). This contrasts with the soluble-anti-Ig cultures that produced the field’s “ABCs can’t become PCs” prior — see In Vitro B Cell Stimulation.

  • Methodological read for this wiki. The assay architecture matters as much as the readout: coculture supplies membrane-presented ligands plus T-derived cytokines simultaneously, which is precisely the condition under which the inhibitory-receptor block on atypical cells is relieved. This strengthens the design rationale for the Tph–B coculture used in dengue (Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue) and suggests that coculture, not soluble-antigen restimulation, is the appropriate functional assay for DENV-specific atypical/DN2 cells.

  • ★ The Be1/Be2 system: polarising the T cell to interrogate the B cell. Naive mouse B cells are co-cultured with allogeneic polarised Th1 (→ Be1) or Th2 (→ Be2) effectors, so the experimental variable is the cytokine environment the T cell supplies rather than a defined recombinant cocktail. Be1 cultures yielded far more CD138⁺CD93⁺ ASCs than Be2 at every timepoint, and the difference was not explained by proliferation — a higher proportion of Be1 cells committed to ASC at each division (see Stone2019 - T-bet Promotes ASC Differentiation by Limiting IFN-gamma Inflammation, mouse, ≥2–4 independent experiments). Combining the assay with genetically modified B cells (Tbx21^−/−^, Ifngr1^−/−^, Cd19^cre/+^Prdm1^fl/fl^) while holding the T cell constant assigns each requirement B-cell-intrinsically, which a whole-animal knockout cannot do.

  • Strengths and limits. The system delivers physiological, cell-contact-plus-cytokine help that defined cocktails cannot reproduce, and its Be1/Be2 contrast is an internal control for cytokine context rather than a separate experiment. Against that, it is an allogeneic mixed lymphocyte reaction with strongly polarised effectors — a deliberately extreme cytokine environment, not a physiological infection microenvironment — and results should not be read as quantitative estimates of in vivo ASC output (see Stone2019 - T-bet Promotes ASC Differentiation by Limiting IFN-gamma Inflammation, mouse). The same lab’s human implementation is described in Zumaquero2019 - IFN-gamma Programs T-bet-hi B Cells for ASC Differentiation.

  • ★ The human implementation: allogeneic polarised Th1/Th2 effectors at a defined 5B:1T ratio. Naive B cells were co-cultured with allogeneic in vitro-generated Th1 (→ Be1) or Th2 (→ Be2) effectors at 0.6×10⁶ cells/ml, ratio 5 B : 1 T, for 5–6 days with IL-2 (50 U/ml) ± IL-21 (10 ng/ml). The T effectors were made by activating purified naive CD4 T cells on plate-bound anti-CD3 (UCHT1) + anti-CD28 (CD28.2) under Th1 (IL-2, IL-12, anti-IL-4) or Th2 (IL-2, IL-4, anti-IL-12, anti-IFN-γ) conditions through three rounds of polarisation (see Zumaquero2019 - IFN-gamma Programs T-bet-hi B Cells for ASC Differentiation, human, n=20 HD + n=40 SLE + in vitro reconstruction). A companion conditioned-media experiment — sorting day-6 B_DN_ cells out of the co-culture and reculturing them in 0.22 µm-filtered media from the original co-culture — separates soluble-factor effects from continued T cell contact. This is the human counterpart of the mouse Be1/Be2 system in Stone2019 - T-bet Promotes ASC Differentiation by Limiting IFN-gamma Inflammation (same laboratory).

Contradictions & Debates

None documented in current wiki sources.

Peripheral Helper T Cell, IL-21, Plasmablast, Memory B Cell, In Vitro B Cell Stimulation, ELISpot, Atypical B Cell, Age-Associated B Cell, IL-21, DN2 B Cell

Sources